Hillsdale Investment Management Inc. Eli Lilly & CO Transaction History

Hillsdale Investment Management Inc.

$1.79 Billion
Q4 2024

A detailed history of Hillsdale Investment Management Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 902 shares of LLY stock, worth $754,983. This represents 0.04% of its overall portfolio holdings.

Number of Shares

902

Previous 1,162 22.38%

Holding current value

$754,983

Previous $1.03 Million 32.36%

% of portfolio

0.04%

Previous 0.09%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$727.2 - $932.06 $189,072 - $242,335	-260 Reduced 22.38%	902 $696,000
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $145,162 - $180,483	188 Added 19.3%	1,162 $1.03 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $297,196 - $372,706	410 Added 72.7%	974 $881,000
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $142,128 - $190,147	-240 Reduced 29.85%	564 $438,000
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $42,015 - $49,530	80 Added 11.05%	804 $468,000
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $186,921 - $257,698	430 Added 146.26%	724 $388,000
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $24,551 - $32,828	70 Added 31.25%	294 $137,000
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $382,074 - $448,728	-1,230 Reduced 84.59%	224 $76,000
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $155,951 - $181,714	-485 Reduced 25.01%	1,454 $531,000
Q3 2022 Nov 10, 2022	SELL	$296.48 - $337.87 $296 - $337	-1 Reduced 0.05%	1,939 $627,000
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $66,895 - $78,544	-240 Reduced 11.01%	1,940 $629,000
Q1 2022 Apr 28, 2022	BUY	$234.69 - $291.66 $431,829 - $536,654	1,840 Added 541.18%	2,180 $624,000
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $542,011 - $701,087	-3,002 Reduced 89.83%	340 $78,000
Q1 2021 Apr 22, 2021	SELL	$164.32 - $212.72 $69,014 - $89,342	-420 Reduced 11.16%	3,342 $625,000
Q4 2020 Feb 09, 2021	SELL	$130.46 - $172.63 $53,488 - $70,778	-410 Reduced 9.83%	3,762 $636,000
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $35,469 - $42,686	-260 Reduced 5.87%	4,172 $686,000
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $2,142 - $2,652	-18 Reduced 0.4%	4,432 $615,000
Q2 2019 Aug 02, 2019	BUY	$110.79 - $129.32 $450,915 - $526,332	4,070 Added 1071.05%	4,450 $494,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $498,668 - $586,969	-4,480 Reduced 92.18%	380 $49,000
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $21,180 - $23,728	-200 Reduced 3.95%	4,860 $562,000
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $1,514 - $1,737	-20 Reduced 0.39%	5,060 $432,000
Q1 2018 May 14, 2018	BUY	$74.21 - $87.6 $371,049 - $438,000	5,000 Added 6250.0%	5,080 $393,000
Q2 2017 Aug 14, 2017	BUY	N/A	80	80 $7,000

Others Institutions Holding LLY

# of Institutions

4,289

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $795B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Account

Hillsdale Investment Management Inc. Eli Lilly & CO Transaction History